Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Halozyme Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Atea Pharmaceuticals Inc. June 18, 202685.6%
-
Ovid Therapeutics Inc. June 6, 202486.8%
-
Atea Pharmaceuticals Inc. June 16, 202371.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Atea Pharmaceuticals Inc. | Option exercise | +29,600 | — | — |
| May 5, 2026 | Halozyme Therapeutics Inc. | Grant or award | +3,796 | — | — |
| Jun 20, 2025 | Atea Pharmaceuticals Inc. | Option exercise | +29,600 | — | — |
| May 1, 2025 | Halozyme Therapeutics Inc. | Grant or award | +4,165 | — | — |
| Jun 16, 2024 | Atea Pharmaceuticals Inc. | Option exercise | +33,150 | — | — |
| Apr 25, 2024 | Halozyme Therapeutics Inc. | Grant or award | +6,501 | — | — |
| May 5, 2023 | Halozyme Therapeutics Inc. | Grant or award | +8,065 | — | — |
| Feb 3, 2023 | Halozyme Therapeutics Inc. | Grant or award | +1,188 | — | — |
Questions about Barbara Gayle Duncan
What boards is Barbara Gayle Duncan on?
Barbara Gayle Duncan sits on the boards of Atea Pharmaceuticals Inc., Halozyme Therapeutics Inc. and Ovid Therapeutics Inc.
How long has Barbara Gayle Duncan served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.